Bioverge Funds, Excision Bio I, LLC

New Filing
CIK: 0001806781·Investing·IDAHO·Filed: Mar 16, 2020
Total Offering

$150,000

Amount Sold

$142,200

Investors

14

First Sale

Mar 12, 2020

Offering Details

Type
Pooled Investment Fund
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Year Incorporated
2020
Non-Accredited Investors
No

Related Persons

NameRole
Neil Bioverge Funds Management,LLC - Littman
Related Person

Company

Bioverge Funds, Excision Bio I, LLC

575 E PARKCENTER BLVD #150

BOISE, ID, 83706

2086961262

SEC Filing

0001806781-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free